Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA Approves First 'Artificial Pancreas' In Medtronic's MiniMed 670G

Executive Summary

The hybrid closed-loop automated insulin delivery system, the first closed-loop system approved anywhere in the world, automatically monitors glucose and provides appropriate basal insulin doses in people with type 1 diabetes.


Related Content

Anthem Joins Other Large Insurers In ‘Artificial Pancreas’ Coverage
#ADA2017: On Visual Learning, Standardization, Data And More Data
Senseonics, TypeZero Join Forces On Artificial Pancreas
Advent Of Artificial Pancreas Tech To Galvanize Fast-Growing Diabetes Market
New Products Drive Medtronic’s Revenue, Profit Growth In Q3
US Approvals Analysis: Strong Q3 For Metabolic-Disease Devices
Abbott Gains US Approval For Pro Version Of Flash Glucose System
From Pipe Dream To Reality: Artificial Pancreas Set To Debut
Medtronic Gets Extra FDA Attention To Hasten Approval Of Next-Gen Insulin Pump


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts